Skip to main content
. 2022 Sep 29;13:985472. doi: 10.3389/fimmu.2022.985472

Table 2.

Outcome issues. Bold values correspond to significative p value.

All participantsn = 100 COVID+ ICU+n = 49 COVID+ICU-n = 24 COVID - ICU+(ICU Controls)n = 16 p value
Outcome
ICU length of stay (days) 14.0 [10.0; 26.0] 15.0 [10.0; 26.0] NR 11.0 [6.8; 18.5] 0.115
Hospital length of stay (days) 20.0 [9.0; 37.0] 27.0 [17.0; 47.0] 6.5 [2.0; 10.0] 26.5 [15.0; 49.8] <0.001
ICU-mortality (%) 16 (24.6) 10 (20.4) NR 6 (37.5) 0.297
In-hospital mortality (%) 25 (28.1) 12 (24.5) 7 (29.2) 6 (37.5) 0.562
Thromboembolic event within hospital: n (%) 13 (14.6) 9 (18.4) 0 (0.0) 4 (25.0) 0.028
Care-related infection: number of patients (%) 32 (36.0) 24 (49) 0 (0) 8 (50) <0.001
Causes of death (n, %)
- Refractory hypoxemia/lung fibrosis 8 (9.0) 1 (2) 7 (29.2) 0 <0.001
- Multiple Organ Failure 15 (16.9) 9 (18.4) 0 (0) 6 (37.5) 0.003
- Withdrawing & Withholding decisions 22 (24.7) 9 (18.4) 7 (29.2) 6 (37.5) 0.234

Data are either median [IQ1; IQ3]) or number (percentage, %).

NR, not relevant.

ICU, intensive care unit.